<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="4" ids="30225">Positron</z:chebi> emission tomography studies on the regional cerebral <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism (rCMRglc) and <z:chebi fb="0" ids="36939">18F</z:chebi>-fluorodopa (<z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="49168">Dopa</z:chebi>) uptake were performed in 3 patients with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e>), a dominantly inherited <z:e sem="disease" ids="C1285162" disease_type="Disease or Syndrome" abbrv="">degenerative disease</z:e> in the cerebellum, brainstem and basal ganglia </plain></SENT>
<SENT sid="1" pm="."><plain>The rCMRglc in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> was found to be significantly decreased in the cerebellum, brainstem, striatum and whole cerebral cortex in comparison to that in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects </plain></SENT>
<SENT sid="2" pm="."><plain>These results of rCMRglc were different from those for dominantly inherited <z:hpo ids='HP_0002542'>olivopontocerebellar atrophy</z:hpo> (dOPCA) or cerebellar cortical degeneration (CCD), however they were similar to those for <z:hpo ids='HP_0003745'>sporadic</z:hpo> <z:hpo ids='HP_0002542'>olivopontocerebellar atrophy</z:hpo> (sOPCA) and multiple system <z:mpath ids='MPATH_127'>atrophy</z:mpath> (MSA) </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="36939">18F</z:chebi>-<z:chebi fb="0" ids="49168">Dopa</z:chebi> uptake in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> was found to be significantly decreased in the putamen and relatively spared in the caudate, which was different from that of MSA </plain></SENT>
<SENT sid="4" pm="."><plain>In addition, these results indicate that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MJD</z:e> showed a dysfunction, not only in the regions with apparent pathological involvement such as cerebellum, brainstem and nigro-striatal dopaminergic system, but also in the cerebral cortex and the striatum where no pathology could be observed using conventional morphological techniques </plain></SENT>
</text></document>